Insider trade

Officer received an award of 2,387 TECH derivative securities

Traded Mar 2, 2026 · Filed Mar 4, 2026

Bio-TechneTECH

2,387
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 2, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 4, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000914190-26-000036
Filed / recorded

Mar 4, 2026, 11:48 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BIO-TECHNE Corp

Issuer CIK

842023

Ticker

TECH

Reporting person

Steven C. Crouse

Relationship

Officer

Officer title

President - Diag & Spatial Bi

Security

Performance Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Mar 2, 2026

Transaction code

A

Shares / units

2,387

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

2,387

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).